S1 Biopharma S1 Biopharma is a company developing drugs for the treatment of sexual dysfunction in both women and men. | ![]() AdoRx Therapeutics AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway. | Pulmotect Pulmotect is a biopharmaceutical company providing products for patients at risk of respiratory diseases. | Yamo Pharmaceuticals Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism. | ||
Founding Date | Founding Date 2016 | Founding Date 2008 | Founding Date N/A | Founding Date 2007 | Founding Date N/A |
Type | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations New York, US HQ New York, US | Locations New York, US HQ | Locations Edinburgh, GB HQ | Locations Houston, US HQ | Locations HQ |
Employees | Employees 620% increase | Employees 4 | Employees N/A | Employees 10 | Employees 6 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 10m (almost 8 years ago) | Latest funding round $ 10.1m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 10m | Total funding raised $ 11.9m | Total funding raised N/A |
S1 Biopharma is a company developing drugs for the treatment of sexual dysfunction in both women and men.
View company
AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
View companyPulmotect is a biopharmaceutical company providing products for patients at risk of respiratory diseases.
View companyYamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism.
View company